Synthesis and biological evaluation of a γ-cyclodextrin-based formulation of the anticancer agent 5,6,11,12,17,18,23,24- octahydrocyclododeca[1,2-b:4,5-b':7,8-b":10,11-b"']tetraindole (CTet)

Molecules

Volumn 15, Issue 6, 2010, Pages 4085-4093

  Lucarini, Simone ^a   De Santi, Mauro ^a   Antonietti, Francesca ^a   Brandi, Giorgio ^a   Diamantini, Giuseppe ^a   Fraternale, Alessandra ^a   Paoletti, Maria Filomena ^a   Tontini, Andrea ^a   Magnani, Mauro ^a   Duranti, Andrea ^a  

^a UNIVERSITY OF URBINO   (Italy)

Author keywords

Cyclodextrin; Breast cancer; Indole cyclic tetramer; Indole 3 carbinol

Indexed keywords

ANTINEOPLASTIC AGENT; GAMMA CYCLODEXTRIN; GAMMA CYCLODEXTRIN DERIVATIVE; GAMMA-CYCLODEXTRIN; INDOLE DERIVATIVE;

ARTICLE; CELL PROLIFERATION; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS; TUMOR CELL LINE; DRUG EFFECTS;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GAMMA-CYCLODEXTRINS; HUMANS; INDOLES; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE;

EID: 77954260092     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15064085     Document Type: Article

References (34)

1. National Research Council. Diet, Nutrition and Cancer; Peter, F. M., Ed.; National Academy Press: Washington, DC, USA, 1982; pp. 358-370.
2. Weng, J.-R.; Tsai, C.-H.; Kulp, S. K.; Chen, C.-S. Indole-3-carbinol as a chemopreventive and anti-cancer agent. Cancer Lett. 2008, 269, 153-163.
3. Safe, S.; Papineni, S.; Chintharlapalli, S. Cancer chemotherapy with indole-3-carbinol, bis (3'-indolyl) methane and synthetic analogs. Cancer Lett. 2008, 269, 326-338.
4. Virtanen, A. I. Studies on organic sulphur compounds and other labile substances in plants. Pythochemistry 1965, 4, 207-228.
5. Wattenberg, L. W.; Loub, W. D. Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles. Cancer Res. 1978, 38, 1410-1413.
6. Bjeldanes, L. F.; Kim, J.-Y.; Grose, K. R.; Bartholomew, J. C.; Bradfield, C. A. Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: Comparisons with 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Proc. Natl. Acad. Sci. USA 1991, 88, 9543-9547.
7. D'Argy, R.; Bergman, J.; Dencker, L. Effects of immunosuppressive chemicals on lymphoid development in fetal thymus organ cultures. Pharmacol. Toxicol. 1989, 64, 33-38.
8. De Kruif, C. A.; Marsman, J. W.; Venekamp, J. C.; Falke, H. E.; Noordhoek, J.; Blaauboer, B. J.; Wortelboer, H. M. Structure elucidation of acid reaction products of indole-3-carbinol: detection in vivo and enzyme induction in vitro. Chem.-Biol. Interact. 1991, 80, 303-315.
9. Chang, Y.-C.; Riby, J.; Chang, G. H.-F.; Peng, B. C.; Firestone, G.; Bjeldanes, L. F. Cytostatic and antiestrogenic effects of 2-(indol-3-ylmethyl)- 3, 3'-diindolylmethane, a major in vivo product of dietary indole-3-carbinol. Biochem. Pharmacol. 1999, 58, 825-834.
10. Riby, J. E.; Feng, C.; Chang, Y.-C.; Schaldach, C. M.; Firestone, G. L.; Bjeldanes, L. F. The major cyclic trimeric product of indole-3-carbinol is a strong agonist of the estrogen receptor signaling pathway. Biochemistry 2000, 39, 910-918.
11. Grose, K. R.; Bjeldanes, L. F. Oligomerization of indole-3-carbinol in aqueous acid. Chem. Res. Toxicol. 1992, 5, 188-193.
12. Brandi, G.; Paiardini, M.; Cervasi, B.; Fiorucci, C.; Filippone, P.; De Marco, C.; Zaffaroni, N.; Magnani, M. A new indole-3-carbinol tetrameric derivative inhibits cyclin-dependent kinase 6 expression, and induces G1 cell cycle arrest in both estrogen-dependent and estrogen-independent breast cancer cell lines. Cancer Res. 2003, 63, 4028-4036.
13. Weng, J.-R.; Tsai, C.-H.; Kulp, S. K.; Wang, D.; Lin, C.-H.; Yang, H.-C.; Ma, Y.; Sargeant, A.; Chiu, C.-F.; Tsai, M.-H.; Chen, C.-S. A potent indole-3-carbinol-derived antitumor agent with pleiotropic effects on multiple signaling patways in prostate cancer cells. Cancer Res. 2007, 67, 7815-7824.
14. Jump, S. M.; Kung, J.; Staub, R.; Kinset, M. A.; Cram, E. J.; Yudina, L. N.; Preobrazhenskaya, M. N.; Bjeldanes, L. F.; Firestone, G. L. N-Alkoxy derivatization of indole-3-carbinol increases the efficacy of the G1 cell cycle arrest and of I3C-specific regulation of cell cycle gene transcription and activity in human breast cancer cells. Biochem. Pharmacol. 2008, 75, 713-724.
15. Guo, W.; Wu, S.; Liu, J.; Fang, B. Identification of a small molecule with synthetic lethality for K-Ras and protein kinase C iota. Cancer Res. 2008, 68, 7403-7408.
16. Ramamoorthy, K.; Navo, M.; Gupta, M. S.; Safe, S. H. AhR-mediated antiestrogenicity of diindolylmethane and analogs in vivo and in vitro. Organohalogen Compd. 1998, 37, 321-324.
17. Ramamoorthy, K.; McDougal, A.; Safe, S. H. Structure-Ah receptor agonist/binding activity relationships of various chlorine-substituted diindolylmethane compounds. Organohalogen Compd. 1999, 42, 363-367.
18. McDougal, A.; Gupta, M. S.; Ramamoorthy, K.; Sun, G.; Safe, S. H. Inhibition of carcinogeninduced rat mammary tumor growth and other estrogen-dependent responses by symmetrical dihalo-substituted analogs of diindolylmethane. Cancer Lett. 2000, 151, 169-179.
19. McDougal, A.; Gupta, M. S.; Morrow, D.; Ramamoorthy, K.; Lee, J.-E.; Safe, S. H. Methylsubstituted diindolylmethanes as inhibitors of estrogen-induced growth of T47D cells and mammary tumors in rats. Breast Cancer Res. Treat. 2001, 66, 147-157.
20. Benabadji, S. H.; Wen, R.; Zheng, J.-B.; Dong, X.-C.; Yuan, S.-G. Anticarcinogenic and antioxidant activity of diindolylmethane derivatives. Acta Pharmacol. Sin. 2004, 25, 666-671.
21. Pisano, C.; Kollar, P.; Gianní, M.; Kalac, Y.; Giordano, V.; Ferrara, F. F.; Tancredi, R.; Devoto, A.; Rinaldi, A.; Rambaldi, A.; Penco, S.; Marzi, M.; Moretti, G.; Vesci, L.; Tinti, O.; Carminati, P.; Terao, M.; Garattini, E. Bis-indols: a novel class of molecules enhancing the cytodifferentiating properties of retinoids in myeloid leukemia cells. Blood 2002, 100, 3719-3730.
22. Giannini, G.; Marzi, M.; Moretti, G. P.; Penco, S.; Tinti, M. O.; Pesci, S.; Lazzaro, F.; De Angelis, F. Synthesis of cycloalkanoindoles by an unusual DAST-triggered rearrangement reaction. Eur. J. Org. Chem. 2004, 2411-2420.
23. Maciejewska, D.; Rasztawicka, M.; Wolska, I.; Anuszewka, E.; Gruber, B. Novel 3, 3'-diindolylmethane derivatives: Synthesis and cytotoxicity, structural characterization in solid state. Eur. J. Med. Chem. 2009, 44, 4136-4147.
24. Sanderson, J. T.; Slobbe, L.; Lansbergen, G. W. A.; Safe, S.; van der Berg, M. 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin and diindolylmethanes differentially induce cytochrome P450 1A1, 1B1, and 19 in H295R human adrenocortical carcinoma cells. Toxicol. Sci. 2001, 61, 40-48.
25. Qin, C.; Morrow, D.; Stewart, J.; Spencer, K.; Porter, W.; Smith, R., III; Phillips, T.; Abdelrahim, M.; Samudio, I.; Safe, S. A new class of peroxisome proliferator-activated receptor. (PPAR.) agonists that inhibit growth of breast cancer cells: 1, 1-Bis (3'-indolyl)-1-(p-substituted phenyl) methanes. Mol. Cancer Ther. 2004, 3, 247-259.
26. Contractor, R.; Samudio, I. J.; Estrov, Z.; Harris, D.; McCubrey, J. A.; Safe, S. H.; Andreeff, M.; Konopleva, M. A novel ring-substituted diindolylmethane, 1, 1-bis[3'-(5-methoxyindolyl)]-1-(p-tbutylphenyl) methane, inhibits extracellular signal-regulated kinase activation and induces apoptosis in acute myelogenous leucemia. Cancer Res. 2005, 65, 2890-2898.
27. Chintharlapalli, S.; Burghardt, R.; Papineni, S.; Ramaiah, S.; Yoon, K.; Safe, S. Activation of Nur77 by selected 1, 1-bis (3'-indolyl)-1-(p-substitued phenyl) methanes induces apoptosis through nuclear pathways. J. Biol. Chem. 2005, 280, 24903-24914.
28. Inamoto, T.; Papineni, S.; Chintharlapalli, S.; Cho S.-D.; Safe, S.; Kamat, A. M. 1, 1-Bis (3'-indolyl)-1-(p-chlorophenyl) methane activates the orphan nuclear receptor Nurr1 and inhibits bladder cancer growth. Mol. Cancer Ther. 2008, 7, 3825-3833.
29. Noguchi-Yachide, T.; Tetsuhashi, M.; Aoyama, H.; Hashimoto, Y. Enhancement of chemicallyinduced HL-60 cell differentiation by 3, 3'-diindolylmethane derivatives. Chem. Pharm. Bull. 2009, 57, 536-540.
30. Chao, W.-R.; Yean, D.; Amin, K.; Green, C.; Jong, L. Computer-aided rational drug design: A novel agent (SR13668) designed to mimic the unique anticancer mechanisms of dietary indole-3-carbinol to block akt signaling. J. Med. Chem. 2007, 50, 3412-3415.
31. Vincent, E.; Shirani, H.; Bergman, J.; Rannug, U.; Janosik, T. Synthesis and biological evaluation of fused thio-and selenopyrans as new indolocarbazole analogues with aryl hydrocarbon receptor affinity. Bioorg. Med. Chem. 2009, 17, 1648-1653.
32. Xue, L.; Schaldach, C. M.; Janosik, T.; Bergman, J.; Bjeldanes, L. F. Effects of analogs of indole-3-carbinol cyclic trimerization product in human breast cancer cells. Chem.-Biol. Interact. 2005, 152, 119-129.
33. Bergman, J.; Högberg, S.; Lindström, J.-O. Macrocyclic condensation products of indole and simple aldehydes. Tetrahedron 1970, 26, 3347-3352.
34. Staub, R. E.; Bjeldanes, L. F. Convenient synthesis of 5, 6, 11, 12, 17, 18-hexahydrocyclononal[1, 2-b:4, 5-b':7, 8-b"]triindole, a novel phytoestrogen. J. Org. Chem. 2003, 68, 167-169.